Shares of marijuana producer Tilray (NASDAQ:TLRY) jumped in Monday’s (June 10) trading session following a special arrangement with its biggest investor to place restrictions on its shares.

According to Tilray, the special agreement with Privateer Holdings will extend the current lockup of 75 million shares of the marijuana company, so if a sale of shares happens it will be heavily restricted.

Tilray opened on Monday at a price of US$44.26. The stock finished the day with an increase of 14.88 percent from the previous day’s close to reach a price point of US$44.57.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

In this transaction, Tilray will acquire Privateer in what is referred to as a downstream merger. Once the acquisition goes through, Tilray will issue Privateer shareholders the same number of its own shares that they currently own.

The resulting new shares will be placed in a lockup and only allowed for sale in special conditions over a two year period.

During the first year, the restriction will be held except for “marketed offerings and/or block trades to institutional investors or via stock sales to strategic investors.”

Privateer financed Tilray’s early days and its path to its initial public offering (IPO) on a senior US exchange in July 2018. Brendan Kennedy, CEO of Tilray, acts as executive chairman for the investment firm as well.

In May, Bloomberg issued a list of the highest-paid executives, with Kennedy securing the second position, fueled in part by the company’s meteoric rise in the stock market.

“We believe this transaction will give Tilray greater control and operating flexibility, while allowing us to effectively manage our public float,” Mark Castaneda, chief financial officer of Tilray, said in a press release.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Seattle-based investment firm Privateer holds an ownership stake of 77 percent of Tilray’s total outstanding shares.

Michael Blue, managing partner of Privateer, said the investment firm sees this deal as maximizing overall returns for its investors, while at the same time giving Tilray “the operating flexibility it needs” in its operations.

In January, Tilray reached the IPO lockup deadline for its shares, which caused the stock to drop double digits in value.

The stock of Tilray is removed from its volatile trading days during which it was a popular trading item that even reached a price of US$300 at one time in 2018.

Over a year-to-date period the company has posted a loss in value of 44.93 percent. However, since the IPO was completed in July 2018, the company has surged 30.33 percent.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

An Emerging Markets Sponsored Commentary

A report just released in early April confirms that the cannabis beverage sector is thriving. According to this report from industry stalwart, Marijuana Business Daily while sales for vapes, pre-rolls and flower were lackluster, cannabis beverages shined:

Keep reading... Show less

BevCanna Enterprises (CSE:BEV,OTCQQ:BVNNF,FWB:7BC) CEO Marcello Leone shared how the company is scaling up its products to forge partnerships and explore opportunities across Canada, the US and Western Europe. 

“Getting your standard processing license and being fully compliant at a federal level is critical in Canada, and we were successful in getting that done. Now we’re getting ready to launch our Keef line of beverages within the next 45 days,” Leone said. 

As a young company, Leone said BevCanna has only started, but it took a four-pronged approach to make sure that it is a revenue-generating company prepared for the opening of many jurisdictions for CBD-based products.

“We are blessed that we have a beautiful infrastructure of our own, a state-of-the-art bottling facility with a capacity of almost 200 million bottles per annum and a strong balance sheet of $55 million. We are in a strong position to scale and grow this company.”

BevCanna has received a Standard Processing License from Health Canada and is now fully authorized to begin production at its full-service, high-capacity beverage manufacturing facility. The company will begin production of its white-label products, number one US cannabis beverage brand Keef and its in-house beverages through licensed Canadian retailers, positioning the company to fully capitalize on the burgeoning Canadian cannabis-infused beverage sector.

Watch the full interview with CEO Marcello Leone above.

Keep reading... Show less

BioHarvest Sciences (CSE: BHSC) will be presenting at the Benzinga Cleantech Small Cap Conference taking place on April 22, 2021. We invite our shareholders and all interested parties to explore cleantech small cap investment opportunities through two days of networking, dealmaking and discovery.

Sign up to get a free spectator pass for the event:

Keep reading... Show less

Positive distributor feedback and strong consumer interest accelerating launch with distributors

Emerging leader in innovative health and wellness beverages and products, BevCanna Enterprises Inc. ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today that its wholly-owned subsidiary Naturo Group has successfully completed its initial shipment of TRACE plant-based products to one of Japan’s largest beverage distributors.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or the “Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced an additional refreshment of its board of directors to further strengthen its leadership in the cannabis industry.

Keep reading... Show less